Get the Stockscreener App
2.85
0.00%
0.00
After Hours:
2.87
0.02
+0.70%
Adial Pharmaceuticals Inc stock is traded at $2.85, with a volume of 74,793.
It is up +0.00% in the last 24 hours and down -51.07% over the past month.
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
See More
Previous Close:
$2.85
Open:
$2.85
24h Volume:
74,793
Relative Volume:
3.39
Market Cap:
$3.17M
Revenue:
-
Net Income/Loss:
$-6.07M
P/E Ratio:
-0.4931
EPS:
-5.78
Net Cash Flow:
$-7.34M
1W Performance:
-16.79%
1M Performance:
-51.07%
6M Performance:
-71.14%
1Y Performance:
-85.32%
1-Day Range:
$2.70
$3.0113
1-Week Range:
$2.70
$3.673
52-Week Range:
$2.70
$32.50
Adial Pharmaceuticals Inc Stock (ADIL) Company Profile
Name
Adial Pharmaceuticals Inc
Sector
Industry
Phone
434-422-9800
Address
1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA
Compare ADIL vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADIL
Adial Pharmaceuticals Inc
|
2.85 | 3.17M | 0 | -6.07M | -7.34M | -5.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-18 | Initiated | Maxim Group | Buy |
| Oct-11-18 | Initiated | Dawson James | Buy |
Adial Pharmaceuticals Inc Stock (ADIL) Latest News
Market Leaders: Whats the fair value of Adial Pharmaceuticals Inc stockJuly 2025 Catalysts & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Why did Adial Pharmaceuticals stock plunge over 20% after hours today? - MSN
Why Is Adial Pharmaceuticals Stock (ADIL) Down Today? - TipRanks
Key facts: Adial Pharmaceuticals to execute reverse stock split; supports FDA trial - TradingView
Dow Jumps Over 200 Points; Uber Shares Fall After Q4 Results - Benzinga
Adial Pharmaceuticals Commends Congressional Directive for Alternative Clinical Trial Endpoints in Substance Use Disorder Treatments - Quiver Quantitative
Adial Pharma To Effect 1 For 25 Reverse Stock Split To Regain Nasdaq Compliance; Shares Plunge - Nasdaq
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04 - marketscreener.com
Super Micro Computer Q2 Earnings Exceed Expectations - Intellectia AI
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Congress directs FDA on alcohol trials, shaping Adial drug's path - Stock Titan
Why Did Adial Pharmaceuticals Stock Plunge Over 20% After Hours Today? - Menafn.com
Adial Pharmaceuticals Applauds New Legislation for Addiction Treatment - Intellectia AI
U.S. Stocks Mixed; Eli Lilly Shares Surge After Earnings Beat - Intellectia AI
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split - Investing.com Nigeria
Adial Pharmaceuticals stock tumbles after announcing 1-for-25 reverse split By Investing.com - Investing.com South Africa
Adial Pharmaceuticals (ADIL) Announces 1-for-25 Reverse Stock Sp - GuruFocus
Adial Pharmaceuticals announces 1-for-25 reverse stock split By Investing.com - Investing.com India
Adial Pharmaceuticals Announces Reverse Stock Split - citybiz
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement - The Manila Times
Adial Pharmaceuticals announces 1-for-25 reverse stock split - Investing.com
Adial reverse split slashes shares, cashes out fractions to stay on Nasdaq - Stock Titan
Retail Trends: Is Adial Pharmaceuticals Inc affected by consumer sentimentStop Loss & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Short Interest Down 24.9% in January - Defense World
Trading Recap: Will Adial Pharmaceuticals Inc benefit from government policy2025 EndofYear Setup & High Conviction Buy Zone Picks - baoquankhu1.vn
Performance Recap: What is Bit Digital Incs market positionWeekly Trend Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
Aug Shorts: Does TELO have declining or rising EPSStock Surge & AI Enhanced Execution Alerts - baoquankhu1.vn
Aug Mood: How sensitive is FS Bancorp Inc to inflationQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - baoquankhu1.vn
What are Adial Pharmaceuticals Inc.’s technical support levelsJuly 2025 Fed Impact & Daily Risk Controlled Trade Plans - mfd.ru
Thermo Fisher Scientific (TMO) Inks Deal to Manufacture Adial Pharmaceuticals ADO4 - MSN
Treasury Yields: Will Adial Pharmaceuticals Inc benefit from government policyJuly 2025 Macro Moves & Technical Confirmation Alerts - baoquankhu1.vn
Published on: 2026-01-22 22:09:40 - baoquankhu1.vn
Lobbying Update: $10,000 of ADIAL PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative
Returns Recap: Whats the MACD signal for Adial Pharmaceuticals IncJuly 2025 Catalysts & Reliable Volume Spike Trade Alerts - baoquankhu1.vn
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045 - Sahm
Adial Pharmaceuticals (ADIL) Secures Patent Application for AD04, Aiming for Long-term Protection - GuruFocus
Adial Pharmaceuticals Announces Publication of International Patent Application for Lead Alcohol Use Disorder Therapy AD04 - Quiver Quantitative
New patent aims to shield alcohol use disorder drug AD04 through 2045 - Stock Titan
Can Adial Pharmaceuticals Inc. stock continue upward trendQuarterly Growth Report & Technical Entry and Exit Tips - Улправда
Is Adial Pharmaceuticals Inc. stock positioned well for digital economy2025 Stock Rankings & Daily Profit Focused Stock Screening - Улправда
Is Adial Pharmaceuticals Inc. stock affected by interest rate hikesJuly 2025 Summary & Fast Exit/Entry Strategy Plans - Улправда
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. - Investing.com India
Adial Pharmaceuticals announces immediate resignation of board director - TipRanks
Adial Pharmaceuticals announces resignation of board member James W. Newman, Jr. By Investing.com - Investing.com South Africa
Adial Pharmaceuticals Announces Board Resignation - TradingView — Track All Markets
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Pullback Watch: Will Adial Pharmaceuticals Inc stock benefit from M A activityWeekly Trade Analysis & Precise Buy Zone Identification - moha.gov.vn
Short Interest in Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Decreases By 31.2% - Defense World
AXIM Biotechnologies (OTCMKTS:AXIM) versus Adial Pharmaceuticals (NASDAQ:ADIL) Financial Comparison - Defense World
Will Adial Pharmaceuticals Inc. stock split again soon2025 Macro Impact & Low Volatility Stock Recommendations - Улправда
Published on: 2025-12-20 18:07:08 - Улправда
Adial Pharmaceuticals Inc Stock (ADIL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):